Trade

with

AbbVie Inc
(NYSE: ABBV)
AdChoices
53.37
+0.47
+0.89%
After Hours :
53.37
0.00
0.00%

Open

53.78

Previous Close

52.90

Volume (Avg)

31.89M (14.74M)

Day's Range

52.90-53.90

52Wk Range

45.50-60.02

Market Cap.

84.95B

Dividend Rate (Yield )

1.68 (3.11%)

Beta

-

Shares Outstanding

1.59B

P/E Ratio (EPS)

20.53 (2.60)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 18.79B

    • Net Income

    • 4.13B

    • Market Cap.

    • 84.95B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 21.65

    • PEG (Price/Earnings Growth) Ratio

    • 1.26

    • Beta

    • -

    • Forward P/E

    • 13.35

    • Price/Sales

    • 4.45

    • Price/Book Value

    • 16.29

    • Price/Cash flow

    • 16.39

      • EBITDA

      • 6.53B

      • Return on Capital %

      • 14.64

      • Return on Equity %

      • 95.03

      • Return on Assets %

      • 14.64

      • Book Value/Share

      • 3.28

      • Shares Outstanding

      • 1.59B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.42 (10/10/2014)

      • Dividend Declaration Date

      • 9/19/2014

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 67.00

        • Credit Rating

        • A-

        • Analysts

        • 3

        • EPS Estimate

        • 4.11

        • Cashflow Estimate

        • 5.03

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 5.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -21.70

          • 7.80

          • Net Income

            Q/Q (last year)

          • 2.80

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 76.18

            • 69.92

            • Pre-Tax Margin

            • 28.27

            • 21.84

            • Net Profit Margin

            • 21.65

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 73.70

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 30.70

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 25.90

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.77

              • 0.32

              • Current Ratio

              • 2.82

              • 1.92

              • Quick Ratio

              • 2.23

              • 1.31

              • Interest Coverage

              • 19.71

              • 17.64

              • Leverage Ratio

              • 5.57

              • 2.03

              • Book Value/Share

              • 3.28

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 21.19

                • 21.41

                • P/E Ratio 5-Year High

                • 23.11

                • 193.96

                • P/E Ratio 5-Year Low

                • 12.52

                • 87.26

                • Price/Sales Ratio

                • 4.58

                • 3.63

                • Price/Book Value

                • 16.78

                • 3.62

                • Price/Cash Flow Ratio

                • 16.39

                • 13.57

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 95.03

                    (-)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 14.64

                    (-)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 22.95

                    (-)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 166.80k

                  • 90.07k

                  • Inventory Turnover

                  • 4.30

                  • 2.46

                  • Asset Turnover

                  • 0.68

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  5.66B
                  Operating Margin
                  30.14
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.39
                  Ownership

                  Institutional Ownership

                  71.21%

                  Top 10 Institutions

                  28.72%

                  Mutual Fund Ownership

                  39.71%

                  Float

                  99.93%

                  5% / Insider Ownership

                  0.11%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Cap Income Builder

                  •  

                    42,982,000

                  • 4.77

                  • 2.70

                  • VA CollegeAmerica Invmt Co of America

                  •  

                    27,805,000

                  • 0.00

                  • 1.75

                  • Vanguard Total Stock Mkt Idx

                  •  

                    24,903,572

                  • -3.54

                  • 1.56

                  • VA CollegeAmerica Cap World Gr and Inc

                  •  

                    22,671,700

                  • 12.87

                  • 1.42

                  • Fidelity® Contrafund® Fund

                  •  

                    20,626,541

                  • 1.86

                  • 1.30

                  • VA CollegeAmerica American Mutual

                  •  

                    20,442,000

                  • 2.25

                  • 1.28

                  • Vanguard Five Hundred Index Fund

                  •  

                    16,524,652

                  • 0.34

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    16,125,554

                  • -0.95

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    15,843,409

                  • -1.10

                  • 0.92

                  • CREF Stock

                  •  

                    8,529,225

                  • -1.34

                  • 0.54

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital Research Global Investors

                  •  

                    102,888,589

                  • +0.95%

                  • 6.46

                  • Vanguard Group, Inc.

                  •  

                    85,718,309

                  • +1.73%

                  • 5.39

                  • State Street Corp

                  •  

                    69,951,507

                  • +3.03%

                  • 4.39

                  • Fidelity Management and Research Company

                  •  

                    56,076,153

                  • -17.19%

                  • 3.52

                  • BlackRock Fund Advisors

                  •  

                    50,041,769

                  • -0.39%

                  • 3.14

                  • Northern Trust Investments, N.A.

                  •  

                    25,445,189

                  • -0.60%

                  • 1.60

                  • Capital World Investors

                  •  

                    19,720,000

                  • -10.95%

                  • 1.24

                  • BlackRock Advisors LLC

                  •  

                    16,803,829

                  • +8.64%

                  • 1.06

                  • Janus Capital Management LLC

                  •  

                    15,490,939

                  • +5.83%

                  • 0.97

                  • State Farm Mutual Automobile Ins CO

                  •  

                    15,061,000

                  • 0.00%

                  • 0.95

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Slow Growth

                  Style

                  Large Core

                  AbbVie Inc was incorporated in Delaware on April 10, 2012, and is a wholly owned subsidiary of Abbott. The company is a research-based biopharmaceutical company with portfolio of proprietary products including a broad line of adult a...morend pediatric pharmaceuticals. The company discovers, develops, manufactures and sells proprietary pharmaceutical products. Its products are used to treat diseases including rheumatoid arthritis, psoriasis, Crohn’s disease, HIV, cystic fibrosis complications. AbbVie also has a pipeline of new medicines, including more than 20 compounds or indications in Phase II or Phase III development across such important medical specialties as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. AbbVie o...moreperates in one business segment—pharmaceutical products. AbbVie competes with other research-based pharmaceuticals and biotechnology companies that discover, manufacture, market, and sell proprietary pharmaceutical products and biologics.lessless

                  Key People

                  Richard A. Gonzalez

                  CEO/Chairman of the Board/Director

                  Mr. William J. Chase

                  CFO/Executive VP

                  Michael Severino

                  Chief Scientific Officer/Executive VP, Divisional

                  Laura J. Schumacher

                  Executive VP, Divisional/General Counsel/Secretary

                  Mr. Carlos Alban

                  Executive VP, Divisional

                  • AbbVie Inc

                  • 1 North Waukegan Road

                  • North Chicago, IL 60064-6400

                  • USA.Map

                  • Phone: +1 847-932-7900

                  • Fax: -

                  • abbvie.com

                  Incorporated

                  2012

                  Employees

                  25,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: